http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-035875-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df53cdf55050f3f4580e1931741875b7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate | 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-035875-A1 |
| titleOfInvention | STABLE PHARMACEUTICAL COMPOSITION OF HMG-COA REDUCTASE INHIBITORS, AND A TABLE FOR ORAL ADMINISTRATION |
| abstract | A pharmaceutical composition comprising, as an active ingredient, an HMG-CoA reductase inhibitor; wherein this composition comprises an amino sugar, with the proviso that the compositions are excluded: comprising dehydroepiandrosterone (DHEA), a descaling agent selected from retinoids, acylated salicylic acid derivatives, or HMG-CoA reductase inhibitors, and derivatives of sugar; and which comprise germs for a koji manufacturing raw material, and monacolin K. A tablet for oral administration, consisting of pravastatin in the form of a sodium salt, one or more fillers, binders, disintegrants, and / or lubricants, and an amino sugar as a pH adjusting agent (basifying), in an amount such that a dispersion of the tablet in water has a pH of 7.0 to 8.7. |
| priorityDate | 2001-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.